Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Immunopathol Pharmacol ; 30(4): 413-419, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29164980

RESUMEN

This study aimed to explore the role and mechanism(s) of flunarizine hydrochloride in the intracerebral hemorrhage (ICH) rats. The 32 adult male Sprague Dawley (SD) rats were randomly assigned into four groups: control group, sham group, ICH group, and FLU + ICH group. The effects of flunarizine hydrochloride were assessed on the basis of hematoma volume, blood-brain barrier (BBB) integrity, and brain water content in the ICH rat models. The role of flunarizine hydrochloride in cell recovery was assessed by behavioral scores, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot assay. Involvement of PI3K/AKT pathway in exerting the effect of flunarizine hydrochloride was also determined. Results showed that the hematoma volume, BBB integrity, and brain water content were significantly decreased in the FLU + ICH group. Cell apoptosis significantly increased in the ICH model group, while flunarizine hydrochloride decreased this increase. The expressions of glial cell line-derived neurotrophic factor (GDNF), neuroglobin (NGB), and p-AKT were increased after flunarizine hydrochloride treatment in ICH rats. In conclusion, flunarizine hydrochloride has protective effects against ICH by reducing brain injury, cell apoptosis, and the activation of P13K/AKT pathway. These findings provide a theoretical basis for the treatment of flunarizine hydrochloride in ICH.


Asunto(s)
Lesiones Encefálicas/tratamiento farmacológico , Bloqueadores de los Canales de Calcio/uso terapéutico , Hemorragia Cerebral/tratamiento farmacológico , Flunarizina/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Animales , Apoptosis/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Barrera Hematoencefálica/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Lesiones Encefálicas/etiología , Lesiones Encefálicas/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Hemorragia Cerebral/complicaciones , Hemorragia Cerebral/metabolismo , Edema/tratamiento farmacológico , Edema/metabolismo , Flunarizina/farmacología , Factor Neurotrófico Derivado de la Línea Celular Glial/genética , Factor Neurotrófico Derivado de la Línea Celular Glial/metabolismo , Globinas/genética , Globinas/metabolismo , Hematoma/tratamiento farmacológico , Hematoma/metabolismo , Masculino , Proteínas del Tejido Nervioso/genética , Proteínas del Tejido Nervioso/metabolismo , Neuroglobina , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fármacos Neuroprotectores/farmacología , Fosfatidilinositol 3-Quinasas/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas Sprague-Dawley , Agua/metabolismo
2.
Medicine (Baltimore) ; 96(3): e5879, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28099346

RESUMEN

Liuwei Dihuang pill (LDP) was assessed for its effects on renal deficiency.90 STZ induced DN rats were divided into groups (n = 22) without treatment (STZ) and LDP treated (STZ-L) (n = 23), Zhenwu decoction treated (STZ-Z) (n = 22), and valsartan treated (STZ-V) (n = 23) groups, with 16 normal control rats. Total urine protein (TP), blood urea nitrogen (BUN), and serum creatinine (Cr) were measured. Superoxide dismutase (SOD), nitric oxide synthase (NOS), and malondialdehyde (MDA) concentrations as well as expression/phosphorylation of SMAD3, SMAD2, and α-SMA, TGF-ß, RI /II, P38, ERK, and NF-kB in renal tissues were determined. In vitro experiments analyzed the effect of enhanced TGF-ß containing rat serums of the STZ groups on mesangial cells with and without transient transfection with a cytoglobin-containing plasmid.LDP treatment reduced the kidney coefficient, serum creatinine, blood urea nitrogen, and urine protein and prevented pathological changes. Expression of SOD and NOS in kidney tissue was increased but MDA expression reduced. LDP modulated multiple pathways, and its administration inhibited the phosphorylation of SMADS, ERK, p38, and the expression of NF-kB, α-SMA, and TGF-ß RI/II, and upregulated the expression of cytoglobin. In vitro studies revealed that overexpression of cytoglobin suppressed phosphorylation of Smad2, ERK, and p38 induced by TGF-ß and expression of NF-kB, α-SMA, and TGF-ß RI.LDP prevented renal fibrosis and protected glomerular mesangial cells by upregulation of cytoglobin and suppression of multiple pathways involving TGF-ß/SMADS, MAPK, NF-kB signaling.


Asunto(s)
Nefropatías Diabéticas/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Globinas/metabolismo , Riñón/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Animales , Citoglobina , Nefropatías Diabéticas/metabolismo , Evaluación Preclínica de Medicamentos , Medicamentos Herbarios Chinos/farmacología , Riñón/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Ratas Sprague-Dawley
3.
Neuroscience ; 337: 339-354, 2016 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-27542528

RESUMEN

Neuroglobin (Ngb) is a respiratory protein that is almost exclusively expressed in the vertebrate nervous system. Despite many years of research, the exact function and even the expression sites of Ngb are still a matter of debate. However, to investigate hypotheses surrounding the potential roles of Ngb, a detailed knowledge of its major and minor expression sites is indispensable. We have therefore evaluated Ngb expression by extensive bioinformatic analysis using publicly available transcriptome data (RNA-Seq). During mammalian brain development, we observed low embryonic expression of Ngb mRNA and an increase after birth, arguing against a role of Ngb in fetal hypoxia tolerance. In adult mouse brain, we found highest Ngb mRNA levels in the hypothalamus, where expression was up to 100-fold stronger than in cerebral cortex, cerebellum or hippocampus, as confirmed by qRT-PCR and Western blotting. High Ngb expression in the hypothalamus was found conserved in humans and other mammals. Thus, Ngb mRNA is expressed at a basal level in many mammalian brain regions, but shows distinctive regional peaks. RNA-Seq analysis further revealed only low levels of Ngb mRNA in retina and testes and no signal in standard tumor cell lines, thus raising questions concerning previous studies and functional hypotheses. In conclusion, this broad-scale expression study may point to distinct Ngb functions for high- and low-expressing cells and tissues and argues against a single, generic role of Ngb as an oxygen supplier or as an endogenous protectant in all nerve cells.


Asunto(s)
Corteza Cerebral/metabolismo , Globinas/metabolismo , Hipocampo/metabolismo , Hipotálamo/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Neuronas/metabolismo , Animales , Cerebelo/metabolismo , Mamíferos , Ratones , Neuroglobina , ARN Mensajero/metabolismo
4.
CNS Neurol Disord Drug Targets ; 15(5): 629-39, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26996171

RESUMEN

Neuroglobin (Ngb) has been demonstrated to be neuroprotective against stroke and neurodegenerative diseases, thus upregulating Ngb might be a novel approach for neuroprotection. In this study we aimed to establish cell-based Ngb reporter systems for screening neuroprotective compounds targeting Ngb upregulation. We developed both mouse and human stable Ngb reporter systems containing a luciferase reporter gene directed by mouse and human Ngb promoter, respectively. To validate these reporter systems, we used them to screen a pool of natural plant compounds. RT-PCR was used to verify the Ngb-upregulating effects of selected compounds, and neurotoxicity assay was used to test their neuroprotection effects in primary cultured neurons. We identified polydatin, genistein, daidzein, biochanin A and formononetin that can upregulate both mouse and human Ngb promoter activity. RT-PCR confirmed that polydatin, genistein and formononetin significantly increased Ngb mRNA expression in primary neurons. Furthermore, formononetin significantly decreased oxygen-glucose deprivation (OGD)-induced neurotoxicity. Moreover, inhibition of cAMP response element-binding protein (CREB) showed that CREB is required for formononetin-induced Ngb upregulation. These results suggest that these Ngb reporter systems are suitable for neuroprotective compound screening, which will be used to screen larger compound libraries for more potent neuroprotectants. This preliminary study will facilitate the development of Ngb-targeted therapeutics for stroke and neurodegenerative diseases.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Globinas/genética , Proteínas del Tejido Nervioso/genética , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Regiones Promotoras Genéticas , Animales , Hipoxia de la Célula/efectos de los fármacos , Células Cultivadas , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Globinas/metabolismo , Glucosa/deficiencia , Humanos , Ratones , Proteínas del Tejido Nervioso/metabolismo , Neuroglobina , Neuronas/metabolismo , Fitoquímicos/farmacología , ARN Mensajero/metabolismo , Regulación hacia Arriba/efectos de los fármacos
5.
Mol Cell Biochem ; 382(1-2): 127-36, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23744534

RESUMEN

In China, the traditional Chinese medicine "YiSui ShenXu Granule" has been used for treating ß-thalassemia over 20 years and known to be effective in clinic. Several purified components from "YiSui ShenXu Granule" are tested in K562 cells to reveal its effect on globin expression and erythroid differentiation, and one of the purified components, emodin, was demonstrated to increase the expression of α-, ε-, γ-globin, CD235a, and CD71 in K562 cells. Moreover, the increase of their expression is emodin concentration-dependent. The mRNA and microRNA (miRNA) expression profiles are further analyzed and 417 mRNAs and 35 miRNAs with differential expression between untreated and emodin-treated K562 cells were identified. Among them, two mRNAs that encode known positive regulators of erythropoiesis, ALAS2, and c-KIT respectively, increased during emodin-induced K562 erythroid differentiation, meanwhile, two negative regulators, miR-221 and miR-222, decreased during this process. These results indicate that emodin can improve the expression of globin genes in K562 cells and also induce K562 cells to erythroid differentiation possibly through up-regulating ALAS2 and c-KIT and down-regulating miR-221 and miR-222.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Emodina/farmacología , Células Eritroides/citología , Células Eritroides/efectos de los fármacos , Regulación Leucémica de la Expresión Génica/efectos de los fármacos , Globinas/genética , Diferenciación Celular/genética , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Células Eritroides/metabolismo , Perfilación de la Expresión Génica , Globinas/metabolismo , Hemoglobinas/metabolismo , Humanos , Células K562 , Proteínas de Neoplasias/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Reproducibilidad de los Resultados
6.
Domest Anim Endocrinol ; 43(3): 213-26, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22503189

RESUMEN

The aim of the present research was to investigate the regulation of gene expression in ovine blood leukocytes during ACTH-induced cortisol release and the effect of dietary administration of botanicals to counteract the evoked response in polymorphonucleate cells (PMNCs). Thirty-six homogeneous Sarda sheep (age, 18±4.1 mo; BW, 38.7±1.3 kg) were allotted to six groups of six sheep each. One group was used as a negative control (Saline) and five groups were treated, every 12 h for 48 h, with 0.5 mL of ACTH agonist (250 µg/mL of tetracosactrin). Before ACTH treatment, four of the five ACTH-treated groups were separated and fed for 22 d with a basal diet supplemented with extracts from Echinacea angustifolia roots (PO+ACTH), Echinacea angustifolia flowers (EA+ACTH), Andrographis paniculata (AP+ACTH), and the bark of Larix decidua milled (LB+ACTH). Control groups (Saline and ACTH) were fed with the same basal diet without botanicals. Total RNA was extracted from blood samples collected before (T0) and after 3 h (T3) and 51 h (T51) from the first ACTH injection, and transcriptome analysis was performed using a custom oligoarray, designed from 12,194 Ovis aries UniGenes on a CombiMatrix platform. At T3, treatment with ACTH caused down-regulation of transcripts (P<0.001) involved in "response to stress" (GADD45A, GADD45B, WRNIP1, and XRCC6) and in "innate immune response" (MAPK3 and NFkBIB). At T51, treatment with ACTH caused down-regulation (P<0.001) of genes involved in "immune response" (IFNG and IL2) and up-regulation (P<0.001) of NF-κB1 and TP53. Each botanical produced a different (P<0.001) molecular signature for these genes at T3 and T51. The most active botanical in modulating transcriptome modifications in PMNCs after ACTH-induced cortisol release was Larix decidua Mill bark followed by Polinacea roots. These botanicals can be viewed as promising feed supplements in ruminants to cope with conditions associated with increased concentrations of plasma cortisol.


Asunto(s)
Hormona Adrenocorticotrópica/farmacología , Alimentación Animal/análisis , Dieta/veterinaria , Regulación de la Expresión Génica/efectos de los fármacos , Extractos Vegetales/farmacología , Ovinos/sangre , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Flores/química , Globinas/genética , Globinas/metabolismo , Inmunidad Innata , Corteza de la Planta/química , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Raíces de Plantas/química , Reacción en Cadena de la Polimerasa , ARN
7.
Zhen Ci Yan Jiu ; 37(5): 380-4, 2012 Oct.
Artículo en Chino | MEDLINE | ID: mdl-23342777

RESUMEN

OBJECTIVE: To observe the effect of electroacupuncture (EA) preconditioning on cerebral ischemia and the role of cerebral neuroglobin (NgB) in EA-induced brain protection in focal cerebral ischemia and reperfusion injury (CI/RI) rats. METHODS: Male SD rats were randomly assigned to sham control, CI/RI 6 h, CI/RI 24 h and CI/RI 72 h groups (n = 6) for observing changes of NgB at different time-points. Additional SD rats were randomly assigned to sham, model, and EA preconditioning (EA-PC) groups (n = 16) for observing changes of cerebral NgB positive cell counts in the ischemic penumbra region 24 h after reperfusion. EA pre-conditioning was applied to "Baihui" (GV 20) for 30 min, once daily for 5 days before CI/RI. CI/RI model was established by occlusion of the right middle cerebral artery and reperfusion for 6 h, 24 h and 72 h respectively. The neurological behavior scores (NBS) of all the rats were evaluated according to Garcia's methods. The cerebral infarct volume was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining. The number of cerebral NgB positive cells was detected by immunofluorescent staining. RESULTS: No infarct loci were found in the sham group. The cerebral infarction volume percentage was significantly higher in the model group than in the EA-PC group (P < 0.01), while the NBS was significantly lower in the model group than in the EA-PC group (P < 0.01). The number of cerebral NgB positive cells in the ischemic penumbra was up-regulated 6 h after CI/RI injury, peaked at 24 h and continued at 72 h. Compared with the sham group, the number of cerebral NgB positive cells of the model group was increased significantly, whereas that of the EA-PC group up-regulated further obviously in comparison with the model group (P < 0.01). CONCLUSION: EA pretreatment has a significant neuroprotective effect on cerebral ischemia-reperfusion, which is closely related to its effect in up-regulating NgB protein expression.


Asunto(s)
Isquemia Encefálica/terapia , Electroacupuntura , Globinas/metabolismo , Proteínas del Tejido Nervioso/metabolismo , Daño por Reperfusión/prevención & control , Puntos de Acupuntura , Animales , Isquemia Encefálica/metabolismo , Isquemia Encefálica/cirugía , Humanos , Masculino , Neuroglobina , Ratas , Ratas Sprague-Dawley , Reperfusión , Daño por Reperfusión/metabolismo , Daño por Reperfusión/terapia
8.
J Neurosci Res ; 89(8): 1276-83, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21538464

RESUMEN

Branched-chain amino acids (BCAAs), valine, isoleucine, and leucine, are widely used among athletes as dietary integrators. Although the occurrence of untoward effects of BCCA supplementation, with particular regard to neurological disturbances, cannot be excluded, no specific studies have been performed so far. The aim of this work was to evaluate the effects of a diet enriched in BCAAs on the expression of oxidative stress pathway genes in the brain of C57Bl/6J mice. Animals were fed a standard or a BCAA diet for 95 days starting from postnatal day 21 until sacrifice. BCAA treatment, at doses comparable to human usage, significantly down-regulated the expression of some antioxidant genes, while up-regulating the expression of some oxygen transporters. In conclusion, it appears that BCAAs administered by diet could alter some specific oxidative stress pathways in the brain. Caution should thus be exercised in the widespread use of BCAAs as dietary integrators in sports practice.


Asunto(s)
Aminoácidos de Cadena Ramificada/administración & dosificación , Encéfalo/efectos de los fármacos , Dieta , Estrés Oxidativo/efectos de los fármacos , Esclerosis Amiotrófica Lateral/etiología , Animales , Apolipoproteínas E/genética , Apolipoproteínas E/metabolismo , Encéfalo/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/genética , Globinas/genética , Globinas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Estrés Oxidativo/genética , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Superóxido Dismutasa-1 , Regulación hacia Arriba/genética
9.
Artículo en Chino | MEDLINE | ID: mdl-21158025

RESUMEN

AIM: To investigate the possible role of rate-limiting enzyme of heme metabolism and globin in the development of the low hemoglobin (Hb), red blood (cell) count (RBC) and hematocrit (Hct) after long-term exercise, and effect of nutrition supplement on sports anemia. METHODS: Male Wistar rats were randomly assigned to three groups (n = 10): control (C), exercise (P) and exercise + nutrition (G). Animals in the P and G groups started treadmill running at 30 m/min, 0% grade, 1 min/time. Running time was gradually increased with 2 min/time during initial 5 weeks and final 4 weeks. In addition, running frequency was 2 times/day except initial 2 weeks. At the end of eleventh week, gene expression of 5-aminolevulinate synthase (ALAS), ferrochelatase, alpha-globin and beta-globin in bone marrow were measured with RT-PCR. Mean-while heme oxygenase 1 (HO-1) activity in liver was measured with immunohistochemical method. RESULTS: Eleven weeks of exercise induced a significant increase in HO-1 and a significant increase in gene expression of beta-globin (P < 0.01, P < 0.05, respectively). Treatment with anti-sports anemia compound dosage led to no significant differences in rate-limiting enzyme of heme metabolism and globin in the exercised rats. The G group had a significantly higher HO-1 level in liver than the C group (P < 0.01). These finds showed that exercise was associated with no significant difference in heme synthetase and alpha-globin gene expression, and significant difference in heme catabolic enzyme and beta-globin gene expression. CONCLUSION: The increase of HO-1 activity in liver might be one of the causes of the lower Hb, RBC and Hct status in exercised rats.


Asunto(s)
Anemia/etiología , Suplementos Dietéticos , Regulación Enzimológica de la Expresión Génica/fisiología , Hemo Oxigenasa (Desciclizante)/metabolismo , Condicionamiento Físico Animal/efectos adversos , 5-Aminolevulinato Sintetasa/genética , 5-Aminolevulinato Sintetasa/metabolismo , Anemia/metabolismo , Anemia/fisiopatología , Animales , Ferroquelatasa/genética , Ferroquelatasa/metabolismo , Globinas/metabolismo , Hemo Oxigenasa (Desciclizante)/genética , Hidroximetilbilano Sintasa/genética , Hidroximetilbilano Sintasa/metabolismo , Masculino , Actividad Motora , Distribución Aleatoria , Ratas , Ratas Wistar
10.
J Neurosci Res ; 87(1): 164-70, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18711728

RESUMEN

Neuroglobin (Ngb) is a recently discovered tissue globin with a high affinity for oxygen that is widely and specifically expressed in neurons of vertebrate central and peripheral nervous systems. Our laboratory and others have shown Ngb overexpression can protect neurons against hypoxic/ischemic insults, but the underlying mechanisms remain poorly understood. In this study, we examined the effects of Ngb overexpression on mitochondrial function, oxidative stress, and neurotoxicity in primary cortical neurons following hypoxia/reoxygenation (H/R). Ngb-overexpressing transgenic neurons (Ngb-Tg) were significantly protected against H/R-induced cell death. Rates of decline in ATP levels, MTT reduction, and mitochondrial membrane potential were significantly ameliorated in Ngb-Tg neurons. Furthermore, Ngb overexpression reduced superoxide anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls. Taken together, these data suggest that Ngb is neuroprotective against hypoxia, in part by improving mitochondria function and decreasing oxidative stress.


Asunto(s)
Globinas/metabolismo , Mitocondrias/fisiología , Proteínas del Tejido Nervioso/metabolismo , Neuronas/fisiología , Neuronas/ultraestructura , Estrés Oxidativo/fisiología , Adenosina Trifosfato/metabolismo , Análisis de Varianza , Animales , Células Cultivadas , Corteza Cerebral/citología , Embrión de Mamíferos , Globinas/genética , Glutatión/metabolismo , Oxigenoterapia Hiperbárica/métodos , Hipoxia , L-Lactato Deshidrogenasa/metabolismo , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Potencial de la Membrana Mitocondrial/genética , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Mitocondrias/genética , Proteínas del Tejido Nervioso/genética , Neuroglobina , Estrés Oxidativo/genética , Fenantridinas/metabolismo , Sales de Tetrazolio , Tiazoles
11.
PLoS One ; 3(4): e1963, 2008 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-18398479

RESUMEN

Position-specific scoring matrices (PSSMs) are useful for detecting weak homology in protein sequence analysis, and they are thought to contain some essential signatures of the protein families. In order to elucidate what kind of ingredients constitute such family-specific signatures, we apply singular value decomposition to a set of PSSMs and examine the properties of dominant right and left singular vectors. The first right singular vectors were correlated with various amino acid indices including relative mutability, amino acid composition in protein interior, hydropathy, or turn propensity, depending on proteins. A significant correlation between the first left singular vector and a measure of site conservation was observed. It is shown that the contribution of the first singular component to the PSSMs act to disfavor potentially but falsely functionally important residues at conserved sites. The second right singular vectors were highly correlated with hydrophobicity scales, and the corresponding left singular vectors with contact numbers of protein structures. It is suggested that sequence alignment with a PSSM is essentially equivalent to threading supplemented with functional information. In addition, singular vectors may be useful for analyzing and annotating the characteristics of conserved sites in protein families.


Asunto(s)
Biología Computacional/métodos , Globinas/química , Proteínas/química , Aminoácidos/química , Animales , Secuencia Conservada , Bases de Datos de Proteínas , Globinas/metabolismo , Humanos , Modelos Estadísticos , Familia de Multigenes , Proteínas/fisiología , Proteómica/métodos , Alineación de Secuencia , Análisis de Secuencia de Proteína
12.
Am J Clin Nutr ; 85(2): 474-9, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17284746

RESUMEN

BACKGROUND: It is customary in Southeast Asia to treat pregnant anemic women with iron supplements, but anemia in this region may be complicated by thalassemia and hemoglobinopathies, which lead to an ineffective response. OBJECTIVE: The aim was to determine whether routine iron supplementation during pregnancy in this area, which has a high prevalence of thalassemia and hemoglobinopathies, is an effective control strategy for iron deficiency anemia. DESIGN: A prospective study was conducted. Seventy-six pregnant women, including 43 who were heterozygous for the hemoglobin E (Hb E) gene, 20 who were heterozygous for Hb E and had alpha-thalassemia, and 13 who were homozygous Hb E, as well as 77 pregnant women who had no thalassemia gene, participated in this investigation. All pregnant women received a daily dose of 120 mg elemental Fe for an average of 133.5 d. Hematologic variables and serum ferritin concentrations were measured before supplementation and after supplementation at the gestational age of 28-32 wk. Differences in hematologic variables and serum ferritin were assessed. RESULTS: Significant differences in hemoglobin, mean corpuscular volume, and mean corpuscular hemoglobin responses were found between the nonthalassemia group and the 3 groups with the Hb E gene after adjustment for the following baseline values: age, body mass index, duration of iron supplementation, and ferritin concentration. Significant differences in the improvements in mean corpuscular volume and mean corpuscular hemoglobin values between the 3 groups indicate a poorer response at the cellular level in the pregnant women with the Hb E gene. Further analysis showed a significant difference in the hemoglobin response only for women who were homozygous for Hb E. CONCLUSION: Iron supplementation during pregnancy is not beneficial for pregnant women who are homozygous for Hb E, but a routine intervention should not cause iron overload, as judged from this short observation period.


Asunto(s)
Suplementos Dietéticos , Regulación de la Expresión Génica/efectos de los fármacos , Globinas/genética , Globinas/metabolismo , Hierro/farmacología , Adulto , Femenino , Humanos , Hierro/administración & dosificación , Embarazo
13.
Brain Res ; 1085(1): 19-27, 2006 Apr 26.
Artículo en Inglés | MEDLINE | ID: mdl-16647691

RESUMEN

Neuroglobin (NGB) is a recently characterized heme globin expressed primarily in retinal nerve cells and at very low levels in endocrine-active regions of vertebrate brains. When artificially over-expressed, NGB reduces the infarct size observed after transient Middle Cerebral Artery occlusion (tMCAo) in rats. This study addresses the post-ischemic NGB expression in vivo. Ten Spontaneously Hypertensive Rats (SHRs) were randomized to tMCAo (n = 6) or sham (n = 4), and euthanized 24 h later. NGB mRNA expression was determined by means of quantitative Reverse Transcription Polymerase Reaction (qRT-PCR). Thirteen animals subjected to either 90 min tMCAo (n = 7) or sham (n = 6) surgery, were euthanized 1 week after surgery. Post-ischemic expression of NGB and the neuronal marker NeuN was studied using free-floating immunohistochemistry. Design-based stereological quantification of NGB- and NeuN-positive cells in the striatum was performed using the optical fractionator. Significantly less NGB mRNA was expressed in the ischemic hemispheres of tMCAo animals after 24 h (P < or = 0.002). At the protein level, we found a significantly lower number of NGB- and NeuN-positive striatal neurons in tMCAo rats (P < or = 0.004). NGB expression was mainly confined to the hypothalamus and amygdala. Less than one out of every two thousand neurons expressed NGB in the striatum. In the ischemic territory we did not observe selective sparing of NGB expressing neurons. No significant change in the NGB/NeuN ratio was observed. Our data indicate that endogenous expressed NGB does not provide protection against ischemic injury induced by tMCAo in SHRs.


Asunto(s)
Expresión Génica/fisiología , Globinas/metabolismo , Infarto de la Arteria Cerebral Media/fisiopatología , Proteínas del Tejido Nervioso/metabolismo , Amígdala del Cerebelo/metabolismo , Amígdala del Cerebelo/patología , Amígdala del Cerebelo/fisiopatología , Análisis de Varianza , Animales , Recuento de Células/métodos , Lateralidad Funcional , Globinas/genética , Hipotálamo/metabolismo , Hipotálamo/patología , Hipotálamo/fisiopatología , Inmunohistoquímica/métodos , Infarto de la Arteria Cerebral Media/patología , Imagen por Resonancia Magnética/métodos , Proteínas del Tejido Nervioso/genética , Neuroglobina , Fosfopiruvato Hidratasa/metabolismo , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas , Ratas Endogámicas SHR , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos
14.
J Med Food ; 9(4): 579-81, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17201648

RESUMEN

This study was designed to document the mechanism through which globin digest, a dietary herbal supplement, might cause weight loss by exploring possible fat malabsorption, calorie malabsorption, energy expenditure, and fat oxidation. Six healthy subjects were placed on an outpatient diet for 14 days and given a meal containing 40.9 g of fat on days 5 and 11, and stools were collected for 72 hours after each meal for analysis of fecal fat content. Four grams of globin digest was given with one meal and placebo with the other. In another separate study, six subjects were placed on a 100-g fat, weight-maintaining diet for 14 days. All food was prepared by the Pennington Center (Baton Rouge, LA) metabolic kitchen. Globin digest (2 g) or placebo was given with each of three meals per day, and stool was collected for calorie determinations during the last 72 hours of each week. Subjects received globin digest during one of the 2 weeks and placebo during the other. Resting metabolic rate and respiratory quotient were measured on the last day of each 1-week period. There was no increase in 72-hour fecal fat or fecal calories by bomb calorimetry during either of the studies. There was no difference in the respiratory quotient. Globin digest did result in an increase in resting metabolic rate. However, this increase was not statistically significant. Globin digest, if effective, does not cause weight loss or fat loss through fat malabsorption or a relative increase in fat oxidation. Future studies are needed to document the efficacy of globin digest for weight loss in humans before further mechanistic investigation is attempted.


Asunto(s)
Caseínas/administración & dosificación , Globinas/administración & dosificación , Glútenes/administración & dosificación , Pérdida de Peso/efectos de los fármacos , Adolescente , Adulto , Anciano , Caseínas/metabolismo , Estudios Cruzados , Dieta , Grasas de la Dieta/administración & dosificación , Grasas de la Dieta/farmacocinética , Suplementos Dietéticos , Metabolismo Energético , Grasas/análisis , Heces/química , Femenino , Globinas/metabolismo , Glútenes/metabolismo , Humanos , Absorción Intestinal , Masculino , Persona de Mediana Edad , Placebos , Hidrolisados de Proteína/administración & dosificación
15.
Acta Biochim Biophys Sin (Shanghai) ; 36(3): 211-7, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15202506

RESUMEN

Huangqi (Astragalus membranaceus), a traditional Chinese medicine, has been used to ameliorate side effects of cancer chemotherapy in China. However, little is known about its molecular mechanisms. Here we show that induction of K562 or HEL cells with 1.5 mg/ml of Huangqi (Hex) (Components extracted from Huangqi) for 3-5 d results in the expression of beta-globin gene in both cell lines and leads to terminal differentiation. Moreover, the apoptosis in HEL cells can be induced by increasing concentration of Huangqi (Hex) to 4.5 mg/ml for 3-5 d. Upregulation of Apaf-1, caspase-3 and acetylcholinesterase (AChE) in HEL cells may play a crucial role in the process of apoptosis. The prospect of inducing expression of adult (beta) globin gene and apoptosis selectively in cancer cells is obviously attractive from a therapeutic point of view.


Asunto(s)
Apoptosis/efectos de los fármacos , Diferenciación Celular/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Globinas/metabolismo , Leucemia Eritroblástica Aguda/patología , Leucemia Eritroblástica Aguda/fisiopatología , Acetilcolinesterasa/metabolismo , Planta del Astrágalo , Astragalus propinquus , Caspasa 3 , Caspasas/metabolismo , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Activación Enzimática/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica , Humanos , Células K562
16.
J Biol Chem ; 278(38): 36505-12, 2003 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-12860983

RESUMEN

Neuroglobin (Ngb) is a newly discovered vertebrate heme protein that is expressed in the brain and can reversibly bind oxygen. It has been reported that Ngb expression levels increase in response to oxygen deprivation and that it protects neurons from hypoxia in vitro and in vivo. However, the mechanism of this neuroprotection remains unclear. In the present study, we tried to clarify the neuroprotective role of Ngb under oxidative stress in vitro. By surface plasmon resonance, we found that ferric Ngb, which is generated spontaneously as a result of the rapid autoxidation, binds exclusively to the GDP-bound form of the alpha subunit of heterotrimeric G protein (Galphai). In GDP dissociation assays or guanosine 5'-O-(3-thio)triphosphate binding assays, ferric Ngb behaved as a guanine nucleotide dissociation inhibitor (GDI), inhibiting the rate of exchange of GDP for GTP. The interaction of GDP-bound Galphai with ferric Ngb will liberate Gbetagamma, leading to protection against neuronal death. In contrast, ferrous ligand-bound Ngb under normoxia did not have GDI activities. Taken together, we propose that human Ngb may be a novel oxidative stress-responsive sensor for signal transduction in the brain.


Asunto(s)
Proteínas de Unión al GTP/química , Globinas/química , Globinas/fisiología , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/fisiología , Secuencia de Aminoácidos , Animales , Encéfalo/metabolismo , ADN Complementario/metabolismo , Bases de Datos como Asunto , Disulfuros/química , Electroforesis en Gel de Poliacrilamida , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/química , Proteínas de Unión al GTP/metabolismo , Globinas/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Guanosina Difosfato/metabolismo , Guanosina Trifosfato/metabolismo , Proteínas de Unión al GTP Heterotriméricas/metabolismo , Humanos , Hierro/química , Modelos Biológicos , Datos de Secuencia Molecular , Proteínas del Tejido Nervioso/metabolismo , Neuroglobina , Estrés Oxidativo , Oxígeno/química , Oxígeno/metabolismo , Unión Proteica , Ratas , Homología de Secuencia de Aminoácido , Transducción de Señal , Resonancia por Plasmón de Superficie , Factores de Tiempo
17.
J Biol Chem ; 278(16): 13912-8, 2003 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-12578825

RESUMEN

Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor that is subject to regulation at the post-transcriptional level. At least two mRNA instability elements reside within the PAI-2 transcript; one in the coding region and another within the 3'-untranslated region (UTR). For the latter, a functional AU-rich motif (ARE) has been identified that provides a binding site for a number of cellular proteins, including the mRNA stability protein, HuR. In this study, we used the yeast three-hybrid system to screen a human leukocyte cDNA library to identify other proteins that associate with the PAI-2 ARE. This screen identified tristetraprolin (TTP) as a PAI-2 mRNA ARE-binding protein. UV cross-linking and immunoprecipitation experiments showed that TTP expressed in HEK293 cells could associate with the PAI-2 ARE in vitro. Co-transfection of plasmids expressing TTP and PAI-2 in HEK293 cells resulted in an increase in the decay rate of PAI-2 mRNA and loss of PAI-2 protein in a process that was dependent upon the PAI-2 3'-UTR. The 29-nt PAI-2 AU-rich element alone was also capable of conferring TTP-dependent mRNA instability to a reporter transcript. The extent of PAI-2 mRNA stability was remarkably sensitive to TTP since TTP-dependent PAI-2 mRNA decay occurred at TTP levels that were below Western blot detection limits. This study identifies TTP as a functional PAI-2 ARE-binding protein that modulates the post-transcriptional regulation of the PAI-2 gene.


Asunto(s)
Antígenos de Superficie , Proteínas de Unión al ADN , Proteínas Inmediatas-Precoces/farmacología , Inhibidor 2 de Activador Plasminogénico/química , Inhibidor 2 de Activador Plasminogénico/metabolismo , ARN Mensajero/metabolismo , Regiones no Traducidas 3' , Northern Blotting , Western Blotting , Línea Celular , Reactivos de Enlaces Cruzados/farmacología , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Proteínas ELAV , Proteína 1 Similar a ELAV , Proteínas Fúngicas/metabolismo , Biblioteca de Genes , Globinas/química , Globinas/metabolismo , Humanos , Modelos Genéticos , Pruebas de Precipitina , Unión Proteica , Procesamiento Postranscripcional del ARN , Proteínas de Unión al ARN/metabolismo , Transcripción Genética , Transfección , Tristetraprolina , Técnicas del Sistema de Dos Híbridos , Rayos Ultravioleta
18.
Shock ; 17(6): 485-90, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12069185

RESUMEN

Hemoglobin is an endotoxin (lipopolysaccharide; LPS)-binding protein that synergistically increases the release of proinflammatory cytokines from the innate immune system in response to LPS. It has been suggested that this activity of hemoglobin facilitates the recognition of Gram-negative bacteria in a wound, thereby maximizing immune efficiency. This synergy may be important to the pathogenesis of a broad spectrum of clinical conditions because elevated hemoglobin levels frequently are observed in patients after the transfusion of red cells, trauma, cardiopulmonary bypass surgery, hemolysis, in addition to other disorders. To determine the molecular basis of the specific hemoglobin-LPS synergy, in this article we tested the effects of globin itself on macrophage responses to LPS. Paradoxically, these studies revealed that globin suppressed tumor necrosis factor (TNF) synthesis in LPS-stimulated murine and human macrophage cultures. LPS comigrated with globin on non-denaturing electrophoretic gels, giving direct evidence for binding. Globin specifically inhibited LPS activity in the standard Limulus assay but did not inhibit interleukin-1beta-mediated TNF synthesis. Iron supplementation of macrophage cultures significantly increased interleukin-1beta-induced TNF release. Intraperitoneal administration of globin protected mice against both LPS-induced lethality and experimentally induced bacterial infection. Thus, the heme-iron moiety of hemoglobin, and not the binding of LPS to globin, enhanced macrophage responses to LPS.


Asunto(s)
Endotoxinas/inmunología , Endotoxinas/toxicidad , Globinas/inmunología , Globinas/farmacología , Choque Séptico/inmunología , Choque Séptico/prevención & control , Animales , Línea Celular , Endotoxemia/prevención & control , Endotoxinas/metabolismo , Globinas/metabolismo , Hemo/inmunología , Humanos , Técnicas In Vitro , Lipopolisacáridos/metabolismo , Lipopolisacáridos/toxicidad , Macrófagos/efectos de los fármacos , Macrófagos/inmunología , Macrófagos/metabolismo , Ratones , Peritonitis/prevención & control , Unión Proteica , Choque Séptico/sangre , Choque Séptico/etiología , Factor de Necrosis Tumoral alfa/biosíntesis
19.
Blood Cells Mol Dis ; 25(1): 1-8, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10349508

RESUMEN

Chitotriosidase, a macrophage marker, which is extremely increased in plasma of Gaucher patients, was measured in patients with beta-thalassemia, an haematological disorder characterized by the genetic defect of beta-globin chains synthesis resulting in unproductive erythropoiesis and enormous expansion of the reticuloendothelial system. Plasma chitotriosidase was increased to a variable extent in 13 of 70 patients with beta-thalassemia major treated with the intense transfusion regimen and iron chelation therapy. It was normal in 22 and slightly elevated in 3 subjects with beta-thalassemia intermedia which were not transfused. The highest levels of plasma chitotriosidase, as high as in Gaucher patients, were found in 7 (10%) of the beta-thalassemia major patients which also had the highest degree of iron overload as judged by their serum ferritin level (> 3000 ng/ml), high SGPT level and elevated urinary iron excretion. To our knowledge, beta-thalassemia is hitherto the only disorder in which an increase of plasma chitotriosidase, comparable to that seen in Gaucher disease, may occur. The increase of plasma chitotriosidase activity in beta-thalassemia patients with high iron overload, could be related to an iron mediated damage to the lysosomal apparatus. In addition, similarly to Gaucher disease, the increased chitotriosidase production in beta-thalassemia might reflect macrophage activation probably related to the intracellular iron overload, storage of erythrocytes membrane break-down products and oxidation of excess alpha-hemoglobin subunits. Further studies are required to define the role of chitotriosidase evaluation to assess the efficacy of chelation therapy in reducing the macrophage activation due to intracellular iron overload in beta-thalassemia.


Asunto(s)
Hexosaminidasas/sangre , Talasemia beta/sangre , Adolescente , Adulto , Niño , Preescolar , Femenino , Enfermedad de Gaucher/sangre , Globinas/genética , Globinas/metabolismo , Humanos , Hierro/metabolismo , Masculino
20.
Blood ; 90(3): 1300-8, 1997 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-9242565

RESUMEN

Two major causes of the anemia in beta-thalassemia are a deficiency in hemoglobin (Hb) beta-subunit (and consequently HbA) synthesis and, due to the resulting excess of Hb alpha-subunits, erythroid cell hemolysis. The hemolytic component might be ameliorated by increasing the intracellular proteolysis of the excess alpha-subunits. Isolated 3H-labeled alpha-chains are known to be degraded primarily by the adenosine triphosphate (ATP)- and ubiquitin (Ub)-dependent proteolysis pathway in unfractionated beta-thalassemic hemolysates. Our objective was to increase this degradation by targeted intervention. Ub aldehyde (Ubal), a synthetic inhibitor of isopeptidases (proteases that hydrolyze the bond between the Ub polypeptide and its protein adduct), was added to reaction mixtures containing a hemolysate from the blood cells of one of four beta-thalassemic donors and 3H-alpha-chains or 3H-alpha-globin as a substrate. Optimum enhancement of ATP-dependent degradation occurred at 0.4 to 1.5 micromol/L Ubal and ranged from 29% to 115% for 3H-alpha-chains and 47% to 96% for 3H-alpha-globin among the four hemolysates. We suggest that Ubal stimulates 3H-alpha-subunit proteolysis by inhibition of an isopeptidase(s) that deubiquitinates, or "edits," Ub-3H-alpha-subunit conjugates, intermediates in the degradative pathway. In control studies, similarly low Ubal concentrations did not enhance the degradation of 3H-alpha2beta2 (HbA) tetramers or inhibit the activities of methemoglobin reductase and four selected glycolysis pathway enzymes. These and other results may be the basis for a therapeutic approach to beta-thalassemia.


Asunto(s)
Adenosina Trifosfato/fisiología , Liasas de Carbono-Nitrógeno , Endopeptidasas/sangre , Globinas/metabolismo , Hemoglobina A/metabolismo , Ubiquitinas/análogos & derivados , Talasemia beta/sangre , Sistema Libre de Células , Evaluación Preclínica de Medicamentos , Hemólisis , Humanos , Liasas/antagonistas & inhibidores , Liasas/sangre , Estimulación Química , Ubiquitinas/farmacología , Talasemia beta/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA